As elevation of circulating FGF‐21 had been documented in patients with muscle‐manifesting mitochondrial diseases, we tried to investigate the FGF‐21 level in other severe neurological diseases and found that it was also elevated in DS. The gene discussed is FGF21; the disease is nervous system disorder.